Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Migraine

Free Subscription Articles published in Neurology Retrieve available abstracts of 52 articles: HTML format

Single Articles

November 2025
1. PENG KP, Mehnert J, May A
   Neuronal Dynamics of Menstrually Related Migraine: A Longitudinal Task-Based fMRI Study.
   Neurology. 2025;105:e214234.
   PubMed     Abstract available
   
   
   
2. COOK JT, Prasad S, Ozudogru S, Ellis CA, et al
   Pearls & Oy-sters: Attacks of Hemiplegic Migraine and Encephalopathy in SLC4A4 Pathogenic Variants.
   Neurology. 2025;105:e214231.
   PubMed     Abstract available
   
   
   
3. TU YH, Huang TC, Tzeng YS, Chen SP, et al
   Prevalence, Clinical Correlates, and Functional Implications of Vestibular Symptoms in Patients With Migraine.
   Neurology. 2025;105:e214248.
   PubMed     Abstract available
   
   
   
4. JANG SI, Kim N, Han K, Lee MJ, et al
   Association Between Obesity and the Risk of Migraine: A Nationwide Cohort Study in South Korea.
   Neurology. 2025;105:e214252.
   PubMed     Abstract available
   
   
   September 2025
5. XUAN Z, Pan Z, Ma C, Lin X, et al
   Reader Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
   Neurology. 2025;105:e210094.
   PubMed    
   
   
   
6. SCHULZ RS, Rist PM, Kurth T
   Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
   Neurology. 2025;105:e210158.
   PubMed    
   
   
   
7. GANESH A, Galetta SL
   Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
   Neurology. 2025;105:e214084.
   PubMed    
   
   
   July 2025
8. ELLER MT, Schwarzova K, Gufler L, Karisik A, et al
   CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review.
   Neurology. 2025;105:e213852.
   PubMed     Abstract available
   
   
   June 2025
9. CAMANNI M, van Gelder MMHJ, Cantarutti A, Nordeng H, et al
   Association of Prenatal Exposure to Triptans, Alone or Combined With Other Migraine Medications, and Neurodevelopmental Outcomes in Offspring.
   Neurology. 2025;104:e213678.
   PubMed     Abstract available
   
   
   March 2025
10. KELLIER D, Anto MM, Hall M, Marin J, et al
    Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache.
    Neurology. 2025;104:e213351.
    PubMed     Abstract available
    
    
    
11. SCHRAMM S, Borner-Schroder C, Reichert M, Ramschutz C, et al
    Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study.
    Neurology. 2025;104:e210235.
    PubMed     Abstract available
    
    
    February 2025
12. HOFFMANN J, Kaube H, Rimmele F, Jurgens TP, et al
    Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial.
    Neurology. 2025;104:e210220.
    PubMed     Abstract available
    
    
    January 2025
13. LIPTON RB, Gandhi P, Tassorelli C, Reuter U, et al
    Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.
    Neurology. 2025;104:e210212.
    PubMed     Abstract available
    
    
    
14. LUBOTZKY A, Pai V, Branson HM, Chowdhury SS, et al
    Teaching NeuroImage: Stroke-Like Migraine Attacks After Radiation Therapy Syndrome.
    Neurology. 2025;104:e210203.
    PubMed    
    
    
    December 2024
15. BONNESEN K, Fuglsang CH, Schmidt M
    Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study.
    Neurology. 2024;103:e210034.
    PubMed     Abstract available
    
    
    
16. WANG K, Sico JJ
    Treating Migraine Patients With Cardiovascular Risks: Are NSAIDs the Safer Choice?
    Neurology. 2024;103:e210196.
    PubMed    
    
    
    November 2024
17. 
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209868.
    PubMed    
    
    
    
18. ALLEN C, Rastall DP
    Teaching NeuroImage: Alice in Wonderland Syndrome: Anatomic Correlation.
    Neurology. 2024;103:e209957.
    PubMed    
    
    
    
19. 
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e210022.
    PubMed    
    
    
    September 2024
20. KUMAR A, Joshi D, Singh VK
    Harlequin Syndrome: A Rare Association With Migraine.
    Neurology. 2024;103:e209792.
    PubMed    
    
    
    
21. SCHULZ RS, Glatz T, Buring JE, Rist PM, et al
    Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2024;103:e209747.
    PubMed     Abstract available
    
    
    
22. LIPTON RB, Harriott AM, Ma JY, Smith JH, et al
    Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
    Neurology. 2024;103:e209745.
    PubMed     Abstract available
    
    
    August 2024
23. AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e209700.
    PubMed     Abstract available
    
    
    July 2024
24. GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209584.
    PubMed     Abstract available
    
    
    May 2024
25. CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al
    Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study.
    Neurology. 2024;102:e209305.
    PubMed     Abstract available
    
    
    
26. REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al
    Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
    Neurology. 2024;102:e209349.
    PubMed     Abstract available
    
    
    April 2024
27. DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al
    Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.
    Neurology. 2024;102:e209248.
    PubMed     Abstract available
    
    
    
28. VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al
    Frequency and Clinical Features of Space Headache Experienced by Astronauts During Long-Haul Space Flights.
    Neurology. 2024;102:e209224.
    PubMed     Abstract available
    
    
    
29. PETROVA M, Besedina O, Hare B, Gupta A, et al
    Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases. (P9-12.005).
    Neurology. 2024;102.
    PubMed     Abstract available
    
    
    
30. BLUMENFELD A, Mechtler L, Cook L, Rhyne C, et al
    Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001).
    Neurology. 2024;102.
    PubMed     Abstract available
    
    
    February 2024
31. LATEEF TM, Dey D, Leroux A, Cui L, et al
    Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With Incident Headache in a Community-Based Sample.
    Neurology. 2024;102:e208102.
    PubMed     Abstract available
    
    
    
32. PIZER JH, Aita SL, Myers MA, Hawley NA, et al
    Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive Multidomain Meta-Analysis.
    Neurology. 2024;102:e208109.
    PubMed     Abstract available
    
    
    
33. SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al
    Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life.
    Neurology. 2024;102:e208074.
    PubMed     Abstract available
    
    
    
34. KEMPNER J
    Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
    Neurology. 2024;102:e209192.
    PubMed    
    
    
    January 2024
35. HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al
    Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
    Neurology. 2024;102:e207813.
    PubMed     Abstract available
    
    
    November 2023
36. CHIANG CC, Fang X, Horvath Z, Cadiou F, et al
    Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964.
    PubMed     Abstract available
    
    
    
37. FRIEDMAN SA, Robbins MS
    Millions of Migraine Attacks, Many Answers, More Questions.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084.
    PubMed    
    
    
    August 2023
38. FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al
    Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648.
    PubMed     Abstract available
    
    
    
39. VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al
    Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677.
    PubMed     Abstract available
    
    
    July 2023
40. VANDERPLUYM JH
    Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications: Striving to Compare Apples to Apples.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672.
    PubMed    
    
    
    
41. SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al
    Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544.
    PubMed     Abstract available
    
    
    
42. PONDER M, Wood ME
    Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
    Neurology. 2023;101:53-54.
    PubMed    
    
    
    June 2023
43. LIU J, Quan S, Zhao L, Yuan K, et al
    Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments.
    Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484.
    PubMed     Abstract available
    
    
    May 2023
44. ORNELLO R, Sposato LA, Sacco S
    Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1033.
    PubMed    
    
    
    
45. LEWIS A, Galetta S
    Editors' Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032.
    PubMed    
    
    
    
46. SCUTELNIC A, Jung S, Schankin CJ
    Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032-1033.
    PubMed    
    
    
    April 2023
47. KARCESKI S
    Migraine and Hormones: A Complex Interaction.
    Neurology. 2023;100:e1849-e1851.
    PubMed    
    
    
    
48. BARBANTI P, Aurilia C, Egeo G, Torelli P, et al
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
    Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292.
    PubMed     Abstract available
    
    
    
49. 
    Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
    Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168.
    PubMed    
    
    
    March 2023
50. BENKLI B, Kim SY, Koike N, Han C, et al
    Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240.
    PubMed     Abstract available
    
    
    
51. SUTHERLAND H, Griffiths L
    It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329.
    PubMed    
    
    
    August 2022
52. ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al
    Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201064.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.